World

Uganda confirms two more cases of mpox

Aug 25, 2024

Kampala [Uganda], August 25: Uganda has confirmed two more mpox virus infections, bringing the number of cases in the east African country to four, according to the health ministry.
The two new patients were infected with the clade 1b strain of the virus, health ministry director general of health services Henry Mwebesa told Reuters, a new offshoot that has triggered global concern.
The World Health Organization declared the recent outbreak of the disease a public health emergency after the new variant, which appears to spread more easily between people, was identified.
Health authorities in Uganda first reported an outbreak of the disease in the country on July 24 when lab tests of samples from two patients at a hospital near the border with Democratic Republic of Congo returned positive for mpox virus.
The latest two cases were confirmed this week, health ministry spokesperson Emmanuel Ainebyoona said, adding that one of the patients was a truck driver. He did not give details of the second patient.
Both patients were isolated at a hospital at Entebbe, a town about 50 km (31 miles) south of the capital Kampala.
Mpox infections cause flu-like symptoms and pus-filled lesions, and transmit through close physical contact. While usually mild, the disease can be fatal.
Uganda borders Congo, where the current outbreak began in January 2023.
Source: Fijian Broadcasting Corporation

More news

Hexaware and Abluva Join Forces to Deliver Secure Agentic AI Solutions for the Life Sciences Industry

Mumbai (Maharashtra) [India]/ Iselin (New Jersey) [US], July 10: Hexaware Technologies, a global provider of IT services and solutions, today announced a strategic partnership with Abluva, an innovator in agentic AI security, to address security challenges posed by autonomous AI agents in the Life Sciences industry. This collaboration brings together Hexaware's deep domain expertise and Abluva's groundbreaking Secure Intelligence Plane to help organizations in the sector deploy generative AI (GenAI) safely and in compliance with industry regulations. As Life Sciences organizations increasingly adopt agentic AI to enhance research, clinical trials, patient data management, and commercial operations, the partnership ensures that AI agents operate in a secure, governed, and auditable environment--without hindering innovation. Delivering Governed and Secure Generative AI Agents for Life Sciences Innovation.

Jul 10, 2025